idarubicin has been researched along with Lymphoma, AIDS-Related in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Propris, MS; De Vellis, A; Gastaldi, R; Gentile, G; Mandelli, F; Martino, P; Pirillo, MF | 1 |
Douglas, R; Michael, B; Nabil, S; Thomas, F | 1 |
Andreotti, M; Avvisati, G; Cafolla, A; Cordone, I; Gastaldi, R; Gentile, G; Giannini, G; Mandelli, F; Martino, P; Palmisano, L; Picardi, V; Torromeo, C | 1 |
2 trial(s) available for idarubicin and Lymphoma, AIDS-Related
Article | Year |
---|---|
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma with or without antiretroviral therapy during antineoplastic agents.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Antiviral Agents; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Female; Humans; Idarubicin; Lymphocyte Count; Lymphoma, AIDS-Related; Lymphoma, Non-Hodgkin; Male; Middle Aged; Vincristine | 2003 |
High dose of idarubicin-based regimen for diffuse large cell AIDS-related non-Hodgkin's lymphoma patients: a pilot study.
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Idarubicin; Lymphoma, AIDS-Related; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Pilot Projects; Treatment Outcome | 2001 |
1 other study(ies) available for idarubicin and Lymphoma, AIDS-Related
Article | Year |
---|---|
Topoisomerase II inhibitor induced leukemia in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Doxorubicin; Etoposide; Homosexuality, Male; Humans; Idarubicin; Leukemia, Myeloid, Acute; Lymphoma, AIDS-Related; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Neoplasm Metastasis; Neoplasms, Second Primary; Topoisomerase II Inhibitors | 2001 |